
UK pharma has been reassured over the use of risk-sharing schemes with health bodies. The latest revisions to the ABPI …
Replacing NICE with a similar system would be detrimental to UK healthcare, according to the Stockholm Network, which further warns …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer

